Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 21 (FTH1P21) is a processed pseudogene mapped to chromosome 4q32.1 in humans. It shares substantial sequence similarity with the active FTH1 gene but lacks protein-coding ability and is usually classified as an inferred, nonfunctional locus. Recent research suggests that pseudogenes in the FTH1 family may have regulatory functions in gene expression, such as acting as competitive endogenous RNAs (ceRNAs) or influencing iron homeostasis, and that some may impact disease processes like cancer by acting as miRNA sponges or generating regulatory RNAs. FTH1P21 itself has not been directly implicated in encoding functional protein or as a validated disease biomarker or drug target.
Not applicable—pseudogene does not encode functional protein. Some literature discusses ceRNA/miRNA sponging effects relevant for regulation of the parental gene (FTH1), but not as a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 21 (FTH1P21).